Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Firsocostat in NASH
NCT02856555Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of firsocostat in Nonalcoholic steatohepatitis (NASH), sponsored by Gilead Sciences. Started Aug 2016; status: completed.
02
Drugs
firsocostat
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02856555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856555.